| Literature DB >> 28524863 |
Yong-Bin Wang1,2, Sheng-Cai Zheng1, Yu-Mei Hu1, Bin Tan1.
Abstract
The axially chiral arylquinazolinone acts as a privileged structural scaffold, which is present in a large number of natural products and biologically active compounds as well as in chiral ligands. However, a direct catalytic enantioselective approach to access optically pure arylquinazolinones has been underexplored. Here we show a general and efficient approach to access enantiomerically pure arylquinazolinones in one-pot fashion catalysed by chiral phosphoric acids. A variety of axially chiral arylquinazolinones were obtained in high yields with good to excellent enantioselectivities under mild condition. Furthermore, we disclosed a method for atroposelective synthesis of alkyl-substituted arylquinazolinones involving Brønsted acid-catalysed carbon-carbon bond cleavage strategy. Finally, the asymmetric total synthesis of eupolyphagin bearing a cyclic arylquinazolinone skeleton was accomplished with an overall yield of 32% in six steps by utilizing the aforementioned methodology.Entities:
Year: 2017 PMID: 28524863 PMCID: PMC5454535 DOI: 10.1038/ncomms15489
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919
Figure 1Representative arylquinazolineones and catalytic asymmetric construction of arylquinazolinone.
(a) Natural products, biologically active compounds and chiral ligand bearing axially chiral arylquinazolinones. (b) Miller's pioneering work. (c) Our strategy for atroposelective construction of arylquinazolineones and its application for total synthesis of eupolyphagin.
Optimization of the reaction conditions*.
| 1 | CHCl3 | 21 | 69 | |
| 2 | CHCl3 | 58 | 49 | |
| 3 | CHCl3 | 88 | 96 | |
| 4 | CHCl3 | 22 | 13 | |
| 5 | CHCl3 | 22 | 38 | |
| 6 | CHCl3 | 58 | 63 | |
| 7 | CHCl3 | 11 | 39 | |
| 8 | CHCl3 | 48 | -67 | |
| 9 | CH2Cl2 | 51 | 67 | |
| 10 | CCl4 | 67 | 91 | |
| 11 | Toluene | 13 | 81 | |
| 12 | EA | 8 | 58 | |
| 13 | CHCl3 | 86 | 74 | |
| 14 | CHCl3 | 99 | 93 | |
| 16 | CHCl3 | 95 | 96 | |
*Unless otherwise specified, the reaction of 1a (0.1 mmol), 2a (0.2 mmol), DDQ (31.9 mg, 0.14 mmol), catalyst CP (10 mol%) and 4 Å MS was carried out in 4.0 ml solvent at 0 °C for 60 h under Ar.
†Isolated yield.
‡Determined by high-performance liquid chromatography analysis.
§Without 4 Å MS.
||At 25 °C.
¶The reaction was performed for 96 h.
#DDQ was added after 48 h and then the reaction was performed for additional 96 h.
Substrates scope of N-aryl anthranilamides*.
*Unless otherwise specified, the reaction of 1a (0.1 mmol), 2a (0.2 mmol), DDQ (31.9 mg, 0.14 mmol), CP3 (7.0 mg, 10 mol%) and 4 Å MS was carried out in 4.0 ml CHCl3 at 0 °C for 96 h under Ar.
†At 25 °C.
‡Performed in c-Hexane:CHCl3=2:1.
Substrates scope of aldehydes*.
*Unless otherwise specified, the reaction of 1a (0.1 mmol), 2a (2.0 mmol), DDQ (1.4 equiv), CP3 (10 mol%) and 4 Å MS was carried out in 4.0 ml CHCl3 at 0 °C for 96 h under Ar.
†At 25 °C.
Further expansion of the generality involving C–C bond cleavage strategy*.
*Unless otherwise specified, the reaction of 1h (0.1 mmol), 5a (0.2 mmol), CP9 (8.0 mg, 10 mol%) and MgSO4 (6.0 mg) was carried out in 4.0 ml mixed solvent (c-hexane:CHCl3=1:1) at 60 °C for 96 h under Ar.
Figure 2Asymmetric total synthesis of eupolyphagin.
The natural product eupolyphagin was effectively synthesized in six steps from easily available starting material with overall yield of 32% in 95% ee.
Figure 3Control experiments proposed reaction processes.
(a) The intermediate 9a was obtained as a single diastereoisomer (dr>20:1) with good enantioselectivity. (b) Two diastereoisomers (dr=20:1) of 9b was isolated. (c) The two diastereoisomers of 9c were inseparable and the following oxidative transformations gave 3p with slightly decrease of enantioselectivity. (d) The isolated intermediates 9d could be transformed to 6a successfully. (e) Proposed reaction processes.